Testing effectiveness (Phase 2)WithdrawnNCT01203618
What this trial is testing
Exploratory Study of Farletuzumab to Treat Resectable, Non-functioning Pituitary Adenomas
Who this might be right for
Resectable, Non-functioning Pituitary Adenoma
Morphotek